Cryopreservation Study Points The Way To Future Skin Indications For Ortec
This article was originally published in The Gray Sheet
Executive Summary
Ortec International will submit results of an equivalence study to FDA demonstrating that its OrCel composite cultured skin (CCS) continues to effectively heal wounds after prolonged cryopreservation.
You may also be interested in...
Ortec OrCel Labeling Should Include Patient Criteria, Steroid Impact - Panel
Ortec International may have to rely on a presentation of pivotal study data in its labeling for OrCel composite cultured skin to make a case for the product's superiority over conventional burn autograft donor site dressings.
Ortec OrCel Labeling Should Include Patient Criteria, Steroid Impact - Panel
Ortec International may have to rely on a presentation of pivotal study data in its labeling for OrCel composite cultured skin to make a case for the product's superiority over conventional burn autograft donor site dressings.
Ortec CCS Venous Leg Ulcer PMA Due 2002; Panel Will Review Burn Indication
Ortec International plans to file a PMA supplement for its composite cultured skin (CCS) for venous skin ulcer treatment by mid-2002, according to company officials.